DDI - Palestras
Permanent URI for this collection
Browse
Browsing DDI - Palestras by Subject "Antibiotic Resistance"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Antibiotic resistance: where are we and where are we going?Publication . Manageiro, VeraAntibiotic resistance is an emerging problem, becoming a serious threat to global public health. Indeed, we are seeing across Europe, namely in Portugal, an increasing number of patients with multidrug-resistant (MDR), extensively-drug resistant (XDR) and pandrug-resistant (PDR) infections, meaning there is no effective treatment available. New resistance mechanisms are disseminating worldwide, and the situation is aggravated by a low investment in this area, and specifically a substantial decline in the research and development of antibacterial agents, among others. Hence, very few new antibacterial classes are brought to market when older classes lose their efficacy. Antibiotic resistance constitutes a global health priority with severe consequences to humans, animals and to the environment, and should be tackled on all fronts in view to the actual concept of “One World - One Medicine - One Health”.
- Application of whole-genome sequencing to detect antibiotic resistance in Gram-negative bacteriaPublication . Manageiro, VeraAntibiotic resistance is an emerging problem, becoming a serious threat to global public health. The causes of its spread are complex, as are the strategies to combat this threat. Following recent improvements in sequencing technologies, whole-genome sequencing (WGS) provides a comprehensive alternative in the evaluation and detection of antibiotic resistance mechanisms. In the scope of the analysis of nonsusceptibility of Gram-negative isolates recovered from human, veterinary and environment samples, we identified the presence of a high diversity of resistance mechanisms. To understand the genetic background of those resistance mechanisms, which included oxyimino-β-lactam, fluoroquinolone and colistin resistance-encoding genes, we performed whole genome and plasmid sequencing using a 454 (Roche) and/or MiSeq (Illumina) sequencing strategy. A set of bioinformatic web tools were used to estimate the presence of pathogenicity determinants, antibiotic resistance (AR) genes, and clinically relevant mobile genetic elements. Indeed, the efficient gene capture and spread of resistance determinants by mobile genetic elements are factors to be taken into account, due to their contribution for the co-selection of multidrug resistant strains in the different settings and environment. Furthermore, WGS might be used with great benefit in combination with phenotypic methods for surveillance purposes.